Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;37(9):1155-1163.
doi: 10.1007/s40273-019-00810-8.

Severity-Adjusted Probability of Being Cost Effective

Affiliations

Severity-Adjusted Probability of Being Cost Effective

Matthijs M Versteegh et al. Pharmacoeconomics. 2019 Sep.

Abstract

Background: In the context of priority setting, a differential cost-effectiveness threshold can be used to reflect a higher societal willingness to pay for quality-adjusted life-year gains in the worse off. However, uncertainty in the estimate of severity can lead to problems when evaluating the outcomes of cost-effectiveness analyses.

Objectives: This study standardizes the assessment of severity, integrates its uncertainty with the uncertainty in cost-effectiveness results and provides decision makers with a new estimate: the severity-adjusted probability of being cost effective.

Methods: Severity is expressed in proportional and absolute shortfall and estimated using life tables and country-specific EQ-5D values. We use the three severity-based cost-effectiveness thresholds (€20.000, €50.000 and €80.000, per QALY) adopted in The Netherlands. We exemplify procedures of integrating uncertainty with a stylized example of a hypothetical oncology treatment.

Results: Applying our methods, taking into account the uncertainty in the cost-effectiveness results and in the estimation of severity identifies the likelihood of an intervention being cost effective when there is uncertainty about the appropriate severity-based cost-effectiveness threshold.

Conclusions: Higher willingness-to-pay thresholds for severe diseases are implemented in countries to reflect societal concerns for an equitable distribution of resources. However, the estimates of severity are uncertain, patient populations are heterogeneous, and this can be accounted for with the severity-adjusted probability of being cost effective proposed in this study. The application to the Netherlands suggests that not adopting the new method could result in incorrect decisions in the reimbursement of new health technologies.

PubMed Disclaimer

Conflict of interest statement

The authors MV, IR, NCB, AA, VRD and WB do not have a conflict of interest to report.

Figures

Fig. 1
Fig. 1
Cost-effectiveness acceptability curves at willingness to pay (WTP) = 50,000 and 80,000 and severity-adjusted probability of being cost effective (SAPCE) of the hypothetical oncology treatment

References

    1. Ramos IC, Versteegh MM, de Boer RA, Koenders JM, Linssen GC, Meeder JG, Rutten-van Mölken MP. Cost effectiveness of the angiotensin receptor neprilysin inhibitor sacubitril/valsartan for patients with chronic heart failure and reduced ejection fraction in the Netherlands: a country adaptation analysis under the former and current Dutch Pharmacoeconomic Guidelines. Value Health. 2017;20(10):1260–1269. doi: 10.1016/j.jval.2017.05.013. - DOI - PubMed
    1. ACP public meeting 05-04-2019. https://www.zorginstituutnederland.nl/binaries/zinl/documenten/adviezen/.... Accessed 23 Apr 2019.
    1. Shah KK. Severity of illness and priority setting in healthcare: a review of the literature. Health Policy. 2009 - PubMed
    1. Wailoo A, Tsuchiya A, McCabe C. Weighting must wait. Pharmacoeconomics. 2009 - PubMed
    1. van de Wetering EJ, Stolk EA, van Exel NJ, Brouwer WBF. Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall. Eur J Health Econ. 2013;1:107–115. doi: 10.1007/s10198-011-0346-7. - DOI - PMC - PubMed

LinkOut - more resources